Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Biotech and Pharmaceuticals

Recent news which mentions Biotech and Pharmaceuticals

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
32 33 Next >
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags LILLY DRN Novo Nordisk A/S Business News
From CNBC.com News
Moderna stock plunges 18% after company lowers 2025 sales forecast by $1 billion
Tags Moderna Inc Biotech and Pharmaceuticals Novavax Inc
From CNBC.com News
Walgreens results top estimates as drugstore chain works to slash costs
Tags Biotechnology Companies Dividends
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags US: News Biotech and Pharmaceuticals Business
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags Healthy Returns Amgen Inc KemPharm Inc
From CNBC.com News
J&J says its lung cancer drug combination keeps people alive longer
Tags Biotech and Pharmaceuticals AstraZeneca PLC Johnson & Johnson
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Health care costs Business News LILLY DRN
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Novo Nordisk A/S Biotechnology Companies
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Breaking News: Markets Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
Tags Business US: News Health & Science
From CNBC.com News
Why Americans are outraged over health insurance — and what could change
Tags Cigna Corp Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Novo Nordisk A/S Merck & Co Inc Business News
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Novo Nordisk A/S Healthy Returns Social issues
From CNBC.com News
UnitedHealth Group CEO addresses Brian Thompson death, says healthcare system is 'flawed'
Tags Business News UnitedHealth Group Inc Biotechnology
From CNBC.com News
Health care stocks fall as lawmakers, patients push for changes to their business models
Tags US: News Business Pharmaceuticals
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Novo Nordisk A/S LILLY DRN Healthy Returns
From CNBC.com News
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.